Snowball logo
logo
KYTX

Kyverna Therapeutics, Inc. Common Stock

KYTX โ€ข NASDAQ
$9.04+$0.64ย  (7.62%)

Frequently asked questions

What sector does Kyverna Therapeutics, Inc. Common Stock (KYTX) operate in?

Kyverna Therapeutics, Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Kyverna Therapeutics, Inc. Common Stock (KYTX) current stock price?

As of the latest data, Kyverna Therapeutics, Inc. Common Stock stock price is $9.04, with a previous close of $8.40. Kyverna Therapeutics, Inc. Common Stock gained $0.64 in the last trading session, representing a 7.62% increase.

What is Kyverna Therapeutics, Inc. Common Stock (KYTX) current market capitalization?

Kyverna Therapeutics, Inc. Common Stock market cap is approximately 547.19 million.

What is Kyverna Therapeutics, Inc. Common Stock (KYTX) Earnings Per Share (EPS)?

The trailing EPS is -$3.64, and the forward EPS is -$2.85.

What is Kyverna Therapeutics, Inc. Common Stock (KYTX) EBITDA?

Kyverna Therapeutics, Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -38.91 million.

Does Kyverna Therapeutics, Inc. Common Stock (KYTX) pay dividends?

No. Kyverna Therapeutics, Inc. Common Stock does not pay a dividend.

What is Kyverna Therapeutics, Inc. Common Stock (KYTX) beta (volatility) score?

Kyverna Therapeutics, Inc. Common Stock has a beta of 2.641, indicating very high volatility compared to the market.